Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer

BACKGROUND: The HER family of proteins (EGFR, HER2, HER3 and HER4) have long been thought to be therapeutic targets for bladder cancer, but previous clinical trials targeting these proteins have been disappointing. Second generation agents may be more effective. OBJECTIVE: The aim of this study was...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Bladder Cancer
Auteurs principaux: Tamura, Shuzo, Wang, Yin, Veeneman, Brendan, Hovelson, Daniel, Bankhead, Armand, Broses, Luke J., Lorenzatti Hiles, Guadalupe, Liebert, Monica, Rubin, John R., Day, Kathleen C., Hussain, Maha, Neamati, Nouri, Tomlins, Scott, Palmbos, Philip L., Grivas, Petros, Day, Mark L.
Format: Artigo
Langue:Inglês
Publié: IOS Press 2018
Sujets:
Research Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5798519/
https://ncbi.nlm.nih.gov/pubmed/29430509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-170144
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires